Enhancing physical performance in chronic obstructive pulmonary disease

Thorax

Volumn 56, Issue 1, 2001, Pages 73-77

  Steiner, M C ^a   Morgan, M D L ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; NUTRITION; OXYGENATION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TRAINING;

EXERCISE THERAPY; FORECASTING; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCLE, SKELETAL; NUTRITION PHYSIOLOGY; OXYGEN; PHYSICAL ENDURANCE;

EID: 0035157321     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.1.73     Document Type: Review

References (72)

1. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation
2. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis
3. Exercise performance after lung transplantation
4. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema
5. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
6. Randomised controlled trial of respiratory rehabilitation
7. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
8. Skeletal muscle dysfunction in chronic obstructive pulmonary disease A statement of the American Thoracic Society and European Respiratory Society
9. Peripheral skeletal muscles and exercise performance in patients with chronic obstructive pulmonary disease
10. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
11. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD
12. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD
13. Peripheral muscle weakness contributes to exercise limitation in COPD
14. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
15. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease
16. Nuclear magnetic resonance spectroscopy: Its role in providing valuable insight into diverse clinical problems
17. 2 and phosphorylcreatine level. Implications for the control of respiration
18. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease
19. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study
20. Anaerobic energy production in human skeletal muscle in intense contraction: A comparison of 31P magnetic resonance spectroscopy and biochemical techniques
21. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease
22. Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination
23. Effects of disuse on the structure and function of skeletal muscle
24. Muscular atrophy following immobilisation. A review
25. Corticosteroids contribute to muscle weakness in chronic airflow obstruction
26. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men
27. Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue
28. The effect of salbutamol on performance in elite nonasthmatic athletes
29. The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol
30. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease
31. Exercise training fails to increase skeletal muscle enzymes in patients with chronic obstructive pulmonary disease
32. Elderly people at home disabled by chronic obstructive pulmonary disease
33. The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease
34. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation
35. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD
36. Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD
37. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease
38. Macronutrients and performance
39. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation
40. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease
41. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health intermittent positive-pressure breathing trial
42. Nutritional support for individuals with COPD: A meta-analysis
43. Exercise training and nutritional supplementation for physical frailty in very elderly people
44. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial
45. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease
46. Foods, nutrition and sports performance. A final consensus statement
47. Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate
48. Metabolic adaptations to endurance training: Substrate metabolism during exercise
49. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease
50. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study
51. Portable liquid oxygen and exercise ability in severe respiratory disability
52. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale
53. Domiciliary Oxygen Therapy Services
54. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation
55. Effects of supplemental oxygen on peripheral haemodynamics and metabolism during exercise in COPD
56. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS
57. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia
58. Metabolic and hemodynamic responses o flower limb during exercise in patients with COPD
59. Improving athletic performance: Is altitude residence or altitude training helpful?
60. "Living high-training low": Effect of moderate-altitude acclimatization with low-altitude training on performance
61. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia
62. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise
63. Interaction between aerobic and anaerobic metabolism during intense muscle contraction
64. Role of pyruvate dehydrogenase in lactate production in exercising human skeletal muscle
65. Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans
66. Effects of dichloroacetate on exercise performance in healthy volunteers
67. The pharmacology of dichloroacetate
68. Creatine and its application as an ergogenic aid
69. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans
70. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia
71. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation